Spray Dried Dispersion

For the active pharmaceutical ingredients (APIs) that fall into BCS (biopharmaceutical classification system) 2 and 4 spaces, advanced formulation approaches are required to enhance their aqueous solubility and bioavailability. Solid amorphous dispersions via spray drying is one of the enabling approaches.

Our Capability

We have mg-g spray drying equipment to enable formulation scientists to include spray-dried dispersions (SDDs) early in compound screening and drug development and are equipped with greater spray drying equipment (tens of kgs) supporting clinical trials and commercialization.